Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

CAS number: 54-06-8

Product Code: REF-C72008

Molecular formula: C9H9NO3

Molecular weight: 179.18

Purity: 97.61%

Product nature: Customized for customers

Appearance: N/A

Storage conditions: -20 ℃, dry ice storage

Chemical name: 3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione

 Hot Tags:Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock。

Synthesis of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61） Reference Standards, 

Complex Impurity Of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Chemical Standards of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Characterization Of Unknown Impurities of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Structure Profiling of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Identification of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Isolation & Purification of Impurity of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Difficult  of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Instability  of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Low-assay of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

Complex Impurity Of Chemical Standards of Carbazochrome Sodium Sulfonate Impurity F（Adrenaline Impurity 61）

    TOSUN PHARM was established in 1999. In China, it is a collection of drugs, APIs, reference listed drugs, impurities, excipients, intermediates import and export, import registration services, generic drug research and development services, innovative drugs and high-end FDF technology transfer, A group company integrating marketing, academic promotion and cooperative production. With a global procurement, R&D and marketing network, it can quickly meet the needs of product R&D, production and market sales of Chinese and global pharmaceutical companies.